David Waldman

Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ.

Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX.

Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.

Part of Places for People Group Ltd., Castle Group Ltd. is a holding British company with interests in residential property management and portable appliance testing. The company is based in Scarborough, UK. Castle Group was acquired by Paladin Group Ltd. on July 14, 2006 for $14.74 million.

GK Technologies, Inc. manufactures wire and cable products, electronic and electrical circuit components, and environmental products. The company is headquartered in Woodcliff Lake, NJ.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

IdentiGEN Ltd. provides DNA-based food tracking and labeling solutions to the agri-food industry. The company was founded by Ciaran Meghen, Ronan Loftus, and Patrick J. Cunningham in 1996 and is headquartered in Dublin, Ireland.

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.

Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland.

Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA.

Population Bio, Inc. is a CNV company to develop therapies and diagnostics. The company was founded by Jim Chinitz, Eli Hatchwell and Peggy S. Eis in 2006 and is headquartered in Melville, NY.

Luxcel Biosciences Ltd. develops, manufactures, and distributes optical fluorescence test solutions for application in the pharmaceutical and food safety industries. It offers MitoXpress Xtra oxygen consumption assay, MitoXpress stress test, MitoXpress FAO assay, pH-Xtra Glycolysis assay, and pH-Xtra Glycolysis stress test. The company was founded by Richard Fernandes and Dmitri Papkovsky in 2002 and is headquartered in Cork, Ireland.

LumaBridge LLC is an oncology clinical research organization that offers comprehensive clinical research organization services, customized trials, and pioneering experience in immuno-oncology. The company is based in San Antonio, TX. The company's mission is to bring life-changing therapies to patients cost-effectively. LumaBridge has a huge network of research sites and offers innovative trial solutions and partnerships. LumaBridge was founded in 2014 by George E. Peoples and Daniel L. Hargrove, and the CEO is J. David Boyle.

Walter Reed Army Medical Center is a general hospital located in Bethesda. The American company operates as a medical center providing healthcare services to patients.

Brooke Army Medical Center provides health care services for military members. The private company is based in Houston, TX.

Orbis Health Solutions LLC operates as a biotech company. The company was founded by Thomas Wagner in 2009 and is headquartered in Greenville, SC.

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

LexisNexis Risk Solutions, Inc. provides content enables workflow solutions for government, legal and risk management professionals. It offer services to communications, financial services, gaming, health care, insurance, retail, complains, data management, fraud, identity and investigation. The company is headquartered in Alpharetta, GA.

LexisNexis Risk Data Management, Inc. develops public record solutions to business, financial services, legal, and government agencies. Its products include Accurint and Securint, which support in critical activities such as debt recovery, due diligence, fraud detection, identity verification, law enforcement, legal investigations, pre-employment screening, resident screening, and data supercomputing. The company was founded by Hank E. Asher in 1998 and is headquartered in Boca Raton, FL.

Aristar Capital Management LLC (Aristar Capital Mgmt) is a Venture Capital firm founded in 2009. The firm is headquartered in New York.

Seed-One Ventures (Seed-One) is a venture capital firm founded in 1997 by Jeff Wolf. The firm is headquartered in Durham, North Carolina.

Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.

Part of Titan Pharmaceuticals, Inc., Ingenex, Inc. is a company based in San Francisco, CA.

Osaka Exchange, Inc. provides markets for index futures, index options, and security options. It also conducts the administration of trading, the administration of transaction participants, and the development and investigative research for new products and trading frameworks. The company was founded on April 1, 1949 and is headquartered in Osaka, Japan.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.